AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Cash and Short Term Investments (Quarterly): 0.397M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 0.397M |
June 30, 2023 | 0.261M |
March 31, 2023 | 0.28M |
December 31, 2022 | 0.645M |
September 30, 2022 | 0.466M |
June 30, 2022 | 0.702M |
March 31, 2022 | 0.448M |
December 31, 2021 | 0.584M |
September 30, 2021 | 0.731M |
June 30, 2021 | 0.615M |
Date | Value |
---|---|
March 31, 2021 | 0.809M |
December 31, 2020 | 0.527M |
September 30, 2020 | 1.107M |
June 30, 2020 | 1.033M |
March 31, 2020 | 0.468M |
December 31, 2019 | 2.352M |
September 30, 2019 | 3.768M |
June 30, 2019 | 5.813M |
March 31, 2019 | 8.586M |
December 31, 2018 | 6.707M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.261M
Minimum
Jun 2023
5.813M
Maximum
Jun 2019
1.167M
Average
0.63M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Homology Medicines Inc (DELISTED) | 82.65M |
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 10.01M |
iBio Inc | 5.302M |
Theriva Biologics Inc | 18.26M |